Fujifilm, Other Pipeline Ebola Drugs Might Be Used Untested
This article was originally published in PharmAsia News
Executive Summary
Fujifilm Holdings and several other global drug makers with Ebola virus treatments in development could soon be asked to make their untested products available to prevent a West African pandemic.